Plasma proteomics and machine learning deliver non-invasive distinction between fibrotic hypersensitivity pneumonitis and idiopathic pulmonary fibrosis
Hypersensitivity pneumonitis (HP) manifests as fibrotic (FHP) and non-fibrotic (NFHP) phenotypes. Clinically distinguishing FHP from idiopathic pulmonary fibrosis (IPF) remains challenging owing to phenotypic overlap, despite divergent management protocols. This investigation sought to develop a plasma proteomics-based framework for differential diagnosis between these entities. A total of 119 subjects were enrolled from the Chinese Interstitial Lung Disease (ILD) National Cohort and the PORTRAY IPF Cohort betwe…

In brief
Between July 2018 and June 2022, investigators enrolled 119 subjects across healthy controls, non-fibrotic HP, fibrotic HP, and IPF cohorts and performed plasma proteomic profiling with WGCNA. They identified 813 proteins, noted enrichment of glycolysis/gluconeogenesis and pyruvate metabolism in FHP, and distilled nine differential proteins to a six-protein signature that was used to train seven machine learning classifiers.
The work matters because FHP and IPF overlap clinically but require divergent management, and a blood-based classifier could reduce reliance on invasive or ambiguous workups. By the July 2026 publication date, the result was a validated proof-of-concept with 71.4% accuracy on an independent test set, not yet a deployed clinical test, with generalizability beyond the two Chinese cohorts still unproven.
Main points
- Study enrolled 119 subjects: 32 healthy controls, 31 non-fibrotic HP, 28 fibrotic HP, and 28 IPF from Chinese ILD National Cohort and PORTRAY IPF Cohort.
- Quantitative plasma proteomics identified 813 proteins and WGCNA highlighted glycolysis/gluconeogenesis and pyruvate metabolism pathways.
- LASSO and recursive feature elimination reduced nine differentially expressed proteins to six-protein signature: H2BC12, SHBG, APCS, PTPRG, IGHV1-58, and GAPDH.
- Seven machine learning algorithms were compared to construct diagnostic models, with SVM selected as optimal on independent test set.
The gain
A six-protein plasma signature tested with SVM distinguished fibrotic hypersensitivity pneumonitis from idiopathic pulmonary fibrosis on an independent test set with 71.4% accuracy, offering a non-invasive diagnostic aid.
The rundown
Researchers profiled plasma from 119 participants enrolled between July 2018 and June 2022 and performed quantitative proteomics, WGCNA, and bioinformatics to map disease-associated proteins and modules.
From nine differentially expressed proteins, a six-protein panel was derived and fed into seven machine learning algorithms; the SVM model delivered the best independent test performance at 71.4% accuracy for FHP versus IPF discrimination.
Sources
- Peer-reviewedJournal of Translational Medicine2026-07-17
ace
The debate